Abstract
BACKGROUND
Sarcoma metastases to the skin are relatively rare, because most involve the lung, liver, or deep soft tissues. The authors
of this report examined the distribution and clinical significance of cutaneous and superficial subcutaneous sarcoma metastases.
METHODS
Sixty-five patients with histologically confirmed dermal and superficial subcutaneous sarcoma metastases were identified in
pathology files from more than 25,000 patients with sarcoma who were evaluated at The University of Texas M. D. Anderson Cancer
Center from 1989 to 2009. Pathology slides and clinical and radiological information were evaluated.
RESULTS
Cutaneous metastases were documented histologically in <0.25% of patients. The mean patient age was 49 years (range, 16-79
years), and there was an equivalent ratio of men to women. The most common source of metastasis was leiomyosarcoma (28 of
65 patients; 43%). The most common region of first skin metastasis was head and neck (33 patients; 51%), and the scalp predominated
(25 patients; 38%). The mean time from primary tumor diagnosis to skin metastasis was 48 months (range, 0-166 months). Fifty-three
patients (81%) had multiple metastases (skin and other). Among the patients who had complete clinical information available,
31 patients (62%) had other metastases diagnosed before skin involvement, 17 patients (34%) had skin metastases diagnosed
first, and 2 patients (4%) had simultaneous presentation. The following clinical outcomes were documented: Twenty-nine patients
(45%) died of disease, 24 patients (37%) remained alive with disease, and 12 patients were lost to follow-up. The mean time
to death was 80 months (range, 9-224 months) after primary diagnosis, 45 months (range, 5-94 months) after the first metastasis
to any site, and 27 months (range, 5-65 months) after the first skin metastasis.
CONCLUSIONS
Sarcoma metastases to the skin are rare. In this large study, leiomyosarcoma was the most common source, and the scalp was
the most frequent site. The majority of patient with skin metastases harbored metastases elsewhere. However, skin was the
initial site of metastasis in approximately 1 in 3 patients. Thus, clinical correlation is needed before establishing a diagnosis
of primary cutaneous sarcoma, particularly leiomyosarcoma of scalp. Finally, the current results indicated that skin metastasis
usually is a late event in sarcoma clinical progression and heralds a poor prognosis.
Links
Authors
Wang WL, Bones-Valentin RA, Prieto VG, Pollock RE, Lev DC, Lazar AJ
Institution
Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. wlwang@mdanderson.org
Source
Cancer 118:11 2012 Jun 1 pg 2900-4MeSH
AdolescentAdult
Aged
Disease Progression
Disease-Free Survival
Female
Humans
Male
Middle Aged
Prognosis
Sarcoma
Skin Neoplasms
Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
21989966
Log In

